WILPAXA
"WILPAXA" is a word mark owned by Teva Pharmaceuticals USA, Inc., filed at the USPTO on June 11, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).
- Status
- Awaiting publication
- Since October 12, 2026
- Filed
- June 11, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99879246
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns WILPAXA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Teva Pharmaceuticals USA, Inc.
Parsippany, United States
Representative
Lori Wolfe
Teva Pharmaceuticals USA, Inc.
What the mark covers
The products and services WILPAXA is filed for, grouped by Nice class.
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and skin disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations
What has happened so far
Steps recorded by the USPTO, newest first.
- Notification of examiners amendment e-mailed
- Approved for pub - principal register
- Examiner's amendment entered
- Examiners amendment e-mailed
- Examiners amendment -written
- Assigned to examiner
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About WILPAXA
Who owns the trademark "WILPAXA"?
The USPTO trademark "WILPAXA" (application 99879246) is owned by Teva Pharmaceuticals USA, Inc.
What is the status of "WILPAXA"?
Its status at the USPTO is: awaiting publication.
Get this data via the API
Everything on this page comes from the Signa API. Pull WILPAXA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019ebf65-a16a-71cd-81cf-7990bad93b01
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019ebf65-a16a-71cd-81cf-7990bad93b01",
"object": "trademark",
"mark_text": "WILPAXA",
"status": {
"primary": "pending",
"stage": "pending_publication"
},
"office_code": "US",
"application_number": "99879246",
"filing_date": "2026-06-11",
"nice_classes": [
5
],
"owners": [
{
"name": "Teva Pharmaceuticals USA, Inc.",
"entity_id": "ent_019fc41c-ecc5-76e9-863d-e500c53224ec"
}
]
}